The MFDS ensures GCP compliance in clinical trials by conducting regular inspections of trial sites, reviewing trial protocols, and monitoring adherence to ethical standards. It evaluates reports of adverse events and audits data integrity. The agency also provides guidance and training to researchers, promoting best practices and maintaining participant safety throughout the trial process.